These results demonstrated that myricetin induced cell cycle arrest at the G2/M phase and autophagy of HCC cells to further suppress HCC growth by inhibiting MARCH1-regulated Stat3 and p38 MAPK signaling pathways. The gene discussed is MARCHF1; the disease is hepatocellular carcinoma.